FINP
FINAL DECISION TRANSACTION PROCESSED BY IB
03/20/2023
Back to search
Official data from USPTO
PHARMTRACE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
PHARMTRACE
ST13
US500000079069710Class
35, 41, 42, 44
Filing
79069710
Registration
3799744
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
53
Latest update
03/20/2023
Classification
Registered
Trademark type
Word
Nice classes
35, 41, 42, 44
Filing date
02/11/2009
Registration date
06/08/2010
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/01/2020
Last transaction
09/01/2020
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
4
Owner type
16
Owner location
Berlin, DE
Examiner
BIBB, SCOTT
Law office
L90
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Pharmtrace klinische Entwicklung GmbH
Representatives
Andrew R. Silverman MacElree Harvey, Ltd.
Technical classification
Nice Classes
Class 35Class 41Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Advertising and advertisement services; marketing services regarding clinical trialsbusiness consulting services with respect to marketing clinical trials; providing advertisingmarketing and promotional services for the pharmaceutical and medical products of othersmarketing services regarding pharmaceutical products by means of promoting clinical trial dataincluding diagnostic imaging procedures; business management; business administration; providing office functions
Class 41
Education servicesproviding classesseminarsworkshops and training in the fields of drug developmentlife cycle managementclinical research and developmentdiagnostic imaging and molecular medicine; provision of trainingsubject-specific further training in the field of clinical research and developmentdiagnostic imaging and molecular medicine; organization and arranging of seminars; entertainmentorganization of exhibitions for cultural or educational purposes and organizing community sporting and cultural events
Class 42
Scientific and technological services and research and design relating theretoscientific research and developmentproviding medical and scientific research information in the fields of pharmaceuticalsclinical trialsdrug developmentlife cycle managementclinical research and developmentdiagnostic imaging and molecular medicine; industrial analysis and research services in the fields of pharmaceuticalsclinical trialsdrug developmentlife cycle managementclinical research and developmentdiagnostic imaging and molecular medicine; design and development of computer hardware and software
Class 44
Medical and veterinary services; hygienic and beauty care for human beings and animals; advisory services relating to pharmaceutical preparations
Publications
History of USPTO decisions and trademark events.
53 publications found
INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
12/09/2022
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
12/07/2022
XXCR
GENERIC MADRID TRANSACTION CREATED
12/07/2022
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
05/01/2021
FINT
FINAL DECISION TRANSACTION PROCESSED BY IB
01/23/2021
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
12/19/2020
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
09/01/2020
71AG
REGISTERED-SEC.71 ACCEPTED
09/01/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/01/2020
ES71
TEAS SECTION 71 RECEIVED
06/04/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/12/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/12/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/12/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/12/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/12/2020
RNWL
INTERNATIONAL REGISTRATION RENEWED
08/23/2019
RFNT
REFUSAL PROCESSED BY IB
07/18/2019
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
06/08/2019
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
12/28/2017
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
09/28/2017
INPC
INVALIDATION PROCESSED
09/28/2017
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
09/27/2017
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
01/28/2017
71.P
REGISTERED - PARTIAL SEC 71 ACCEPTED
01/27/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/19/2017
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
01/10/2017
PR71
POST REGISTRATION ACTION MAILED - SEC.71
07/13/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/11/2016
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/03/2016
ES71
TEAS SECTION 71 RECEIVED
06/03/2016
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/12/2013
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/09/2010
FIMP
FINAL DISPOSITION PROCESSED
09/09/2010
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/08/2010
R.PR
REGISTERED-PRINCIPAL REGISTER
06/08/2010
PUBO
PUBLISHED FOR OPPOSITION
03/23/2010
NPUB
NOTICE OF PUBLICATION
03/03/2010
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
02/17/2010
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/17/2010
ACEC
AMENDMENT FROM APPLICANT ENTERED
01/20/2010
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/20/2010
ALIE
ASSIGNED TO LIE
01/20/2010
PAPER RECEIVED
01/12/2010
RFNT
REFUSAL PROCESSED BY IB
09/19/2009
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/15/2009
RFRR
REFUSAL PROCESSED BY MPU
07/15/2009
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/15/2009
CNRT
NON-FINAL ACTION WRITTEN
07/14/2009
MAFR
APPLICATION FILING RECEIPT MAILED
07/14/2009
DOCK
ASSIGNED TO EXAMINER
07/10/2009
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/10/2009
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/09/2009
Continuous trademark protection
Get notified about every new filing that threatens PHARMTRACE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.